UnitedHealth Group has completed its acquisition of home health and hospice provider Amedisys for $3.3 billion ($101 per share), following a settlement with the U.S. Department of Justice that resolved antitrust concerns. The deal, originally announced in June 2023, faced a two-year delay due to regulatory hurdles and a DOJ lawsuit, but was ultimately approved after UnitedHealth agreed to divest 164 care locations across 19 states (generating $528 million in revenue) to The Pennant Group and BrightSpring Health Services. Amedisys, which serves over 465,000 patients across 38 states and earned $621 million in Q2 net service revenue, has now become a wholly-owned subsidiary of UnitedHealth and ceased trading on Nasdaq, making UnitedHealth one of the largest hospice providers in the U.S. following its 2023 acquisition of LHC Group for $5.4 billion.
The M&A market for healthcare companies continues to build on STRATEGIC opportunities and a fragmented market. Consolidations along with unprecedented demand are driving scale across the continuum of care. The strategic corporate buyers and private equity investors remain committed to acquiring strong businesses that are well prepared for a transaction. Across the continuum of care, these buyers and investors are looking for well established, profitable businesses and offering prime valuations and options for management.
Do you know the current market value of your business? We do! We are here to help you plan, prepare, explore and succeed in executing your strategic options.
Contact Paragon Ventures for more information.
800-719-1555
